James Krellenstein Profile picture
Jul 1 25 tweets 11 min read
Proud of the activism @PrEP4AllNow and others did to get CDC to send more #monkeypox doses to NYC & US. Due to that work, vaccinations will restart soon. But Biden's vaccine strategy is too small & slow to protect 🏳️‍🌈🏳️‍⚧️ communities. We must demand better. What needs to happen: 🧵
The USG OWNS more than a MILLION doses of monkeypox vaccine *ready to go* stuck in freezers in Denmark. These doses COULD have been brought to the US weeks ago had the Biden admin. ordered @US_FDA to inspect the facility, but they didn't, so now they may not come till AUGUST.
The Biden admin. inaction has consequences. NYC, for example, will get less than *6,000* doses over the next few weeks, meaning we will rapidly run out of doses AGAIN as the virus spreads unchecked in Queer persons.
The admin. only plans to have 1.6M doses (only enough for 800K people) available by the *end of this year* for the *entire country*. This is not enough to protect EVEN JUST the MOST AT RISK people (>1.8M ppl). To cover this population would require a *minimum* of 3.6M doses.
We could provide enough doses for all of the most vulnerable people rapidly if steps are taken now. The U.S. owns an additional >15.2M doses of vaccine that just need to be put into vials. But the admin. has no plan to get this done, despite repeated warnings from experts.
What steps should we demand the admin take now? On Tuesday, @prep4allnow & @PIH urged the administration to pursue a three step strategy to ensure robust vaccine supply over the coming weeks. Admin’s response? Crickets. documentcloud.org/documents/2207…
Hey @rajpanjabi, @FDACommisioner, @ASPRgov, when you get a chance, can you know, respond to our letter? I know y’all are busy, but our communities kind of can’t access vaccines, and are unnecessarily getting infected?
Step 1: Since 2007, US taxpayers have spent over $2 billion developing, manufacturing & stockpiling the JYNNEOS monkeypox vaccine to prep for a potential outbreak. Over *1 MILLION* doses are currently ready to go in freezers in Denmark. So why can't we access them?
Vaccines, like all drugs, need to be produced in facilities that comply with a set of regulations called “current good manufacturing practices” or cGMP. For a vaccine to be used in the US, @US_FDA needs to certify that the facility that made the doses is compliant with cGMP.
The JYNNEOS vaccine is made in a factory outside of Copenhagen by @bavariannordic. For reasons that have not been made public, @US_FDA failed to reinspect the facility recently, allowing the factory's US cGMP compliance certificate to expire.
This means that the doses that were produced since the certificate expired can’t be used in the US, until we reinspect the facility. Major fuck up. The entire point of us spending billions of dollars stockpiling JYNNEOS doses was so we would be prepared for a potential outbreak.
But because the admin didn’t ensure that @US_FDA did its job, we can’t use them now, even as queer people are getting infected. And we *already* know that the @bavariannordic facility is complying with cGMP regulations and the doses are safe.
How? @EMA_News DID ITS JOB and reinspected the @bavariannordic facility a year ago and issued a cGMP certificate (valid till 2024). And @US_FDA could choose to recognize EMA’s certificate under a 2017 “mutual recognition” agreement.
But it doesn’t seem willing to do this. @US_FDA could also reinspect the facility — something that should’ve been done weeks ago. Either way, queer people face an uncontrolled outbreak & can’t access doses WE NEED NOW & ALREADY OWN because this admin fucked up.
Remember, once @US_FDA allows those doses to be used in the US, a MILLION more doses of monkeypox vaccine will be available almost instantly. (A direct flight from Copenhagen to NYC takes 7 hours, 23 minutes.)
STEP 2: We own an additional 15.2 million+ doses of monkeypox vaccine that are not yet put into vials. (The doses are instead stored frozen in large, multi-liter plastic bags called “bioprocess bags” in Denmark).
*Last month* the administration spent $100 million+ to begin “lyophilizing” (freeze drying) these doses, to make them last longer and not require refrigeration. The problem is that freeze drying takes a long time — it won’t be complete till *2025*.
But we need those doses ASAP. So the admin needs to 1) ask @bavariannordic to pause its freeze drying campaign, and 2) figure out how to put those *liquid doses* into vials, a process known as “liquid fill and finish”, as quickly as possible.
This should be achievable. In 2013, US taxpayers starting spending *tens of millions* of dollars to build a “fill and finish manufacturing network” (FFMN), designed to “liquid fill and finish” 9.75 million doses of vaccine *a week* on average in the event of an outbreak.
We need @US_FDA and @ASPRgov to figure out if the FFMN can be used to fill and finish these monkeypox doses ASAP. If it can, we could manufacture 15 million more MPX doses ASAP.
If it can’t, we need to find another manufacturer who could fill and finish these doses. Luckily, the world built *BILLIONS of DOSES PER YEAR* of fill and finish capacity for COVID vaccines. As demand has waned, much of that capacity is now idle.
We need to use that capacity to fill and finish these doses. @US_FDA and @ASPRgov need to start searching the world for compatible fill and finish capacity for monkeypox.This needs to be done ASAP.
But even 15 million more doses are not going to be enough. Monkeypox is a global outbreak, and @bavariannordic can only manufacture ~30 million doses of JYNNEOS per year. Which brings us to step 3.
Step 3: We need @US_FDA and @ASPRgov to look for facilities around the world that can begin manufacturing more JYNNEOS drug substance. We need to ensure that everyone in the world who needs it, can access it.
Tl;dr we have the ability to end the monkeypox outbreak. Our government has the resources and the tools to do this, but apparently won’t, unless we force them.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with James Krellenstein

James Krellenstein Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @jbkrell

Nov 27, 2021
This @mattyglesias tweet is getting a lot of play, but it is fundamentally wrong. Let's start with the basics; Omicron is not the "South African variant"; although it was first *detected* in South Africa, it probably did not *originate* there. Short 🧵
New variants of SARS-CoV-2 are detected by RNA sequencing. But inequity in healthcare systems means in much of the world, few if any, cases of COVID are sequenced. Of the 6 states that border🇿🇦, 5 have been unable to sequence a *single case* in the last 30 days. From @GISAID.
This is the case in much of e.g. southern Africa.🇿🇦is an exception, it has built a world class molecular surveillance system. But that also means that if a new variant developed somewhere else, it is likely to be the first place to *detect* it, even if its from somewhere else.
Read 11 tweets
May 4, 2021
So this is a common question to ask -- if Moderna has pledged to not enforce their patents, why can't we start production everywhere? Three reasons:🧵
The 1st, Moderna doesn't own every patent that is used in its vaccine and in the machines used to make their vaccine. Put simply, it can't pledge to not enforce patents it doesn't own. Let's take the most obvious example of this. 2/n
Both NIH/Moderna & Pfizer/BioNTech vaccine use modified nucleosides, specifically n1-methylpseudouridine (rather than uridine, the "U" in the RNA genetic alphabet). in their mRNA This allows the vaccine to express a protein without triggering a cell's antiviral defenses. 3/n
Read 9 tweets
Apr 25, 2021
I know we are all applauding @JoeBiden for his response to India today, but, to be honest, I think Biden's response is actually really bad. And it shows that nearly 100 days into his administration, they still don't have a plan for ensuring global vaccination. 🧵
First, as @zainrizvi has pointed out, the WH was clear that the materials that would be sent to Serum Institute of India would be for Covishield (the SI version of AZ/Oxford). The only problem? There was NO materials shortage for Covishield that was inhibiting production.
Instead, @SerumInstIndia cannot access supplies for the OTHER COVID-19 vaccine it produces, Covovax, their version of @Novavax, *and not Covishield*. Serum Institute has been 100% explicit about this (once again h/t @zainrizvi):
Read 7 tweets
Mar 23, 2021
As the world reels this morning from the @AstraZeneca news, remember that this problem + the general difficulty of comparing different COVID-19 vaccines is due to a decision by the @NIH to not run head to head trials because pharma *didn't want them to*. 🧵
The problem is that each COVID-19 vaccine was evaluated in its own clinical trial(s), each with a different statistical design, end point definition, recruitment strategy etc. A better way would have been to compare each vaccine against each other in a "platform clinical trial".
This would of made direct comparison between each vaccine candidate far easier, because they would have been evaluated on a common trial design and critically, would have generated important info to guide policy makers on selecting candidates for further manufacturing scale up
Read 8 tweets
Feb 5, 2021
The @Dereklowe piece sort of misses the point. Yes, there is no idle mRNA vaccine production capacity in the pharma industry that could simply be repurposed to make more COVID-19 vaccines. But we could rapidly *build* more capacity, as we did across the world last year. 🧵
Before we get deep into the weeds, lets remember, in January/Feb, the world had basically no commercial scale mRNA vaccine production capacity. By December, private industry (with a lot of public funds) built 3 billion+ doses / year scale capacity
So what happened? Companies like @pfizer, @BioNTech_Group, and @LonzaGroup (which makes the bulk of finished drug substance for @moderna_tx ) rapidly built mRNA vaccine production capacity inside existing manufacturing facilities.
Read 19 tweets
Feb 3, 2021
I am a little confused by this @nytimes reporting by @MarcSantoraNYT and @RebeccaDRobbins on the new AZD1222 data. First of all, the claim that this data is the “first” to document evidence that a COVID vaccine can result in a reduction in transmission seems to be wrong. Image
In fact, just last week, Israeli researchers documented a 50% reduction in both symptomatic and asymptomatic infections in individuals who took a single dose of the Pfizer mRNA shot in a retrospective cohort study. medrxiv.org/content/10.110…
This is a preprint, but so is the new Astra data! Furthermore, the original AZD1222 publication in the Lancet in December *also* reported on preliminary PCR positivity in asymptomatic individuals in COV002 as well. thelancet.com/action/showPdf… Image
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(